Indo Amines Limited (INDOAMIN) Fair Value & Analysis
Basic Materials · IN · Market cap ₹9.6B
Fair value as of: Jul 3, 2026
From 16 valuation models · updated yesterday
Share price −3.8% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹83.06 – ₹170.12 · fair‑value band ₹121.62 – ₹204.40 · the ₹132.33 price screens below the ₹162.15 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Indo Amines Limited (INDOAMIN) currently trades at ₹132.33, while our model-based Fair Value estimate is ₹162.15 — implying the stock looks roughly 22.5% undervalued today. We read business quality at 50/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Indo Amines Limited generated revenue of ₹11.6B at a net margin of 6.8%. Revenue grew 11.3% year over year. It earns a return on equity of 22.3%. Net debt stands at ₹2.9B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Indo Amines Limited engages in the manufacture, distribution, and sale of fine, performance, and specialty chemicals in India and internationally. The company's fine chemicals comprise aliphatic and aromatic amines, aliphatic and aromatic nitriles, halides, alcohols, cycloalkanols, cycloalkanones, acids and esters, advanced intermediates, amine hydrochlorides, ethanol amines, and other products. Its specialty chemicals include fatty acids, amides, amines, di-amines, tertiary amines, polyamines, amine ethoxylates, and ammonium quats. The company's performance chemicals comprise anticaking, antifoaming, antistatic, antistripping, antibacterial/antislime, and floatation agents, as well as granulating aids, defoamers, emulsifiers, curing aids, bitumen emulsifiers, corrosion inhibitors, demulsifiers, and antibacterial products. Its products are used in pharmaceuticals, agrochemicals, fertilizers, petrochemicals, perfumery chemicals, road construction, pesticides, dyes and intermediates, …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Indo Amines Limited reported revenue of ₹11.6B in FY2026 versus ₹7.8B in FY2022, a compound +10.5%/yr. Reported net income was ₹793M in FY2026, compounding +36.2%/yr from FY2022.
Is INDOAMIN fairly valued? → Check now
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €443.00 | €109.98 | -75% |
| Shin-Etsu Chemical Co SHECY | $22.62 | $12.94 | -43% |
| BASF SE BAS | €49.17 | €23.76 | -52% |
| Ningxia Baofeng Energy Group 600989 | ¥23.43 | ¥34.39 | +47% |
| Dow Inc D1OW34 | R$43.92 | R$86.14 | +96% |
| Ganfeng Lithium Group 002460 | ¥67.60 | ¥22.08 | -67% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Indo Amines Limited (INDOAMIN) undervalued?
What is the fair value of INDOAMIN?
What is the quality score of INDOAMIN?
What is the revenue of Indo Amines Limited (INDOAMIN)?
What is the net profit margin of INDOAMIN?
Does Indo Amines Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.